You have 9 free searches left this month | for more free features.

Adavosertib

Showing 1 - 25 of 44

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer Trial (Adavosertib, Gemcitabine)

Withdrawn
  • Pancreatic Cancer
  • (no location specified)
Jun 10, 2022

Advanced Solid Tumours Trial in Denver, Sarasota, Nashville (AZD1775, MEDI4736)

Active, not recruiting
  • Advanced Solid Tumours
  • Denver, Colorado
  • +2 more
Aug 18, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Boston, Houston

Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Adavosertib
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jan 12, 2023

Advanced Solid Tumours Trial in Spain, United Kingdom, United States (Adavosertib)

Active, not recruiting
  • Advanced Solid Tumours
  • Adavosertib
  • Newnan, Georgia
  • +14 more
Mar 15, 2022

Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation Trial in Canada, Netherlands, United States (Adavosertib, Paclitaxel,

Active, not recruiting
  • Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
  • Adavosertib
  • +4 more
  • Gilbert, Arizona
  • +19 more
Aug 23, 2022

Uterine Serous Carcinoma Trial in Worldwide (Adavosertib)

Active, not recruiting
  • Uterine Serous Carcinoma
  • Adavosertib
  • Burbank, California
  • +26 more
Jan 10, 2023

CNS Embryonal Tumor With Rhabdoid Features, CNS Embryonal Tumor, Not Otherwise Specified, CNS Ganglioneuroblastoma Trial in

Active, not recruiting
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Adavosertib
  • Irinotecan Hydrochloride
  • Birmingham, Alabama
  • +23 more
Oct 7, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Adavosertib
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

Solid Tumors Trial run by the NCI (MK-1775 (AZD1775))

Completed
  • Solid Tumors
  • MK-1775 (AZD1775)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2021

Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)

Completed
  • Advanced Malignant Solid Neoplasm
  • Adavosertib
  • +5 more
  • Aurora, Colorado
  • +7 more
Apr 11, 2022

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States (Adavosertib)

Suspended
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Adavosertib
  • Duarte, California
  • +8 more
Mar 15, 2022

Prostate Cancer Trial in Canada (Adavosertib, Savolitinib, Darolutamide)

Recruiting
  • Prostate Cancer
  • Adavosertib
  • +6 more
  • Edmonton, Alberta, Canada
  • +10 more
May 9, 2022

Metastatic Triple Negative Breast Cancer Trial in Worldwide (Olaparib Continuous (28-Day cycle) 300 mg BD., Ceralasertib 160 mg

Active, not recruiting
  • Metastatic Triple Negative Breast Cancer
  • Olaparib Continuous (28-Day cycle) 300 mg BD.
  • +2 more
  • Birmingham, Alabama
  • +140 more
Nov 17, 2022

Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Adavosertib
  • +5 more
  • Chicago, Illinois
  • +4 more
Jun 10, 2021

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Adavosertib
  • +5 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Advanced Gastric Adenocarcinoma Trial in Seoul (AZD1775, paclitaxel)

Completed
  • Advanced Gastric Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical center
Jun 13, 2022

Lung Cancer Trial in Tampa, Columbus (Carboplatin, Paclitaxel, AZD1775)

Active, not recruiting
  • Lung Cancer
  • Tampa, Florida
  • +1 more
Feb 2, 2023

Uterine Cancer Trial in Boston (AZD1775)

Recruiting
  • Uterine Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jul 5, 2022

Hypopharynx Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Larynx Cancer Trial in United Kingdom (AZD1775,

Completed
  • Hypopharynx Squamous Cell Carcinoma
  • +2 more
  • Birmingham, West Midlands, United Kingdom
  • +5 more
Nov 9, 2022

Cancer Trial in United States (AZD2281, AZD5363, AZD1775)

Active, not recruiting
  • Cancer
  • New Haven, Connecticut
  • +3 more
Sep 14, 2021

Small Cell Lung Cancer Trial in Seoul (AZD1775)

Completed
  • Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 18, 2021

Carcinoma, Squamous Cell of Head and Neck Trial in Chapel Hill (AZD1775, Cisplatin, Intensity Modulated Radiotherapy Treatments)

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jun 27, 2021

Epithelial Ovarian Cancer Trial in Amsterdam (MK-1775 and carboplatin)

Active, not recruiting
  • Epithelial Ovarian Cancer
  • MK-1775 and carboplatin
  • Amsterdam, Netherlands
    Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
Dec 21, 2021

Children, Adolescents and Young Adults With Refractory or Recurrent Malignancies Trial in Worldwide (Ribociclib, Topotecan,

Unknown status
  • Children, Adolescents and Young Adults With Refractory or Recurrent Malignancies
  • Copenhagen, Denmark
  • +6 more
Feb 23, 2021

Metastatic Colorectal Cancer Trial in New York (AZD1775, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • New York, New York
    Laura and Isaac Perlmutter Cancer Center
Oct 8, 2020